Thymoquinone abrogates methamphetamine-induced striatal neurotoxicity and hyperlocomotor activity in mice
- PMID: 34447447
- PMCID: PMC8356713
- DOI: 10.4103/1735-5362.319577
Thymoquinone abrogates methamphetamine-induced striatal neurotoxicity and hyperlocomotor activity in mice
Abstract
Background and purpose: Methamphetamine (METH) abuse has devastating consequences on the nervous system. There are limited therapy choices in METH abuse with reduced effectiveness and elevated recurrence rates. Thymoquinone (TQ), the most bioactive constituent of Nigella sativa seeds exerts neuroprotective effects mainly via antioxidant properties. This study aimed to evaluate the effect of TQ against METH-induced striatal neurotoxicity and hyperlocomotor activity in mice.
Experimental approach: Our groups of animals received METH (10 mg/kg) four times a day with 2 h intervals. Normal saline or TQ (5, 10, or 20 mg/kg) was injected intraperitoneally 30 min before METH administration. Control and sham groups received vehicle or TQ, respectively. The rectal temperature and behavioral tests including the open field for locomotor activity and rotarod for motor coordination were evaluated. The level of superoxide dismutase (SOD), as well as pathological changes, were also assessed in the striatum region.
Findings/results: No significant differences in rectal temperatures were observed among treated groups. Administration of METH increased locomotor activity and did not change motor coordination. TQ co-administration with METH significantly reduced the central and total locomotion and the mean latency to fall off the rotarod in a dose-dependent manner compared with the METH group. TQ also alleviated the METH-induced decrease in the activity of SOD.TQ, especially at the high dose, reduced the METH-induced reactive gliosis level.
Conclusion and implications: In conclusion, TQ prevents the enhanced locomotor activity, antioxidant impairment, and morphological striatal damage caused by METH in mice. TQ may be a potential candidate for the treatment of specific METH-induced brain disorders or neurological diseases.
Keywords: Adverse drug effects; Methamphetamine; Nervous system; Nigella sativa; Substance abuse; Thymoquinone.
Copyright: © 2021 Research in Pharmaceutical Sciences.
Conflict of interest statement
The authors declared no conflicts of interest in this study.
Figures
Similar articles
-
Thymoquinone Improved Nonylphenol-Induced Memory Deficit and Neurotoxicity Through Its Antioxidant and Neuroprotective Effects.Mol Neurobiol. 2022 Jun;59(6):3600-3616. doi: 10.1007/s12035-022-02807-5. Epub 2022 Mar 30. Mol Neurobiol. 2022. PMID: 35355194
-
Evaluating the Protective Effects of Thymoquinone on Methamphetamine-induced Toxicity in an In Vitro Model Based on Differentiated PC12 Cells.Altern Lab Anim. 2024 Mar;52(2):94-106. doi: 10.1177/02611929241237409. Epub 2024 Mar 6. Altern Lab Anim. 2024. PMID: 38445454
-
Nigella sativa and thymoquinone attenuate oxidative stress and cognitive impairment following cerebral hypoperfusion in rats.Metab Brain Dis. 2019 Aug;34(4):1001-1010. doi: 10.1007/s11011-019-00394-4. Epub 2019 Apr 23. Metab Brain Dis. 2019. PMID: 31016464
-
A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases.CNS Neurol Disord Drug Targets. 2018;17(6):412-420. doi: 10.2174/1871527317666180702101455. CNS Neurol Disord Drug Targets. 2018. PMID: 29962349 Review.
-
Thymoquinone, a major constituent in Nigella sativa seeds, is a potential preventative and treatment option for atherosclerosis.Eur J Pharmacol. 2021 Oct 15;909:174420. doi: 10.1016/j.ejphar.2021.174420. Epub 2021 Aug 12. Eur J Pharmacol. 2021. PMID: 34391767 Review.
Cited by
-
Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases.Pharmaceuticals (Basel). 2022 Mar 27;15(4):408. doi: 10.3390/ph15040408. Pharmaceuticals (Basel). 2022. PMID: 35455405 Free PMC article. Review.
-
A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.Naunyn Schmiedebergs Arch Pharmacol. 2022 Aug;395(8):921-931. doi: 10.1007/s00210-022-02248-w. Epub 2022 May 23. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35604430 Review.
-
Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review.Front Pharmacol. 2024 Jul 17;15:1428492. doi: 10.3389/fphar.2024.1428492. eCollection 2024. Front Pharmacol. 2024. PMID: 39086393 Free PMC article.
-
Nanowired Delivery of Mesenchymal Stem Cells with Antioxidant Compound H-290/51 Reduces Exacerbation of Methamphetamine Neurotoxicity in Hot Environment.Adv Neurobiol. 2023;32:317-352. doi: 10.1007/978-3-031-32997-5_8. Adv Neurobiol. 2023. PMID: 37480465
-
Recent Advances in the Treatment of Spinal Cord Injury.Arch Bone Jt Surg. 2024;12(6):380-399. doi: 10.22038/ABJS.2023.73944.3424. Arch Bone Jt Surg. 2024. PMID: 38919744 Free PMC article. Review.
References
-
- Rahmati M, Eskandari MR. Cytotoxic effects of methamphetamine in rat hepatocytes. Res Pharm Sci. 2012;7(5):S186.
-
- Prakash MD, Tangalakis K, Antonipillai J, Stojanovska L, Nurgali K, Apostolopoulos V. Methamphetamine: effects on the brain, gut and immune system. Pharmacol Res. 2017;120:60–67. DOI: 10.1016/j.phrs.2017.03.009. - PubMed
LinkOut - more resources
Full Text Sources